Delayed Survival Benefit of Enzalutamide Plus Radium‐223 in Metastatic Castration‐Resistant Prostate Cancer: A Time‐Dependent Analysis of Reconstructed Individual Patient Data From the <scp>PEACE</scp> ‐3 Trial
Delayed Survival Benefit of Enzalutamide Plus Radium‐223 in Metastatic Castration‐Resistant Prostate Cancer: A Time‐Dependent Analysis of Reconstructed Individual Patient Data From the PEACE ‐3 Trial
Motohiro Fujiwara, Soichiro Yoshida, Hideto Fukushima, Kenji Tanabe et al.
Journal
International Journal of Urology
Topics
Prostate Cancer Treatment and Research
article
Delayed Survival Benefit of Enzalutamide Plus Radium‐223 in Metastatic Castration‐Resistant Prostate Cancer: A Time‐Dependent Analysis of Reconstructed Individual Patient Data From the PEACE ‐3 Trial
Teikyo University Hospital (JP), National Cancer Center Hospital East (JP), Zigong First People's Hospital (CN), Institute of Science Tokyo (JP), Teikyo University (JP)